Eight new flavonoids, including two
β-hydroxy/methoxychalcones,
velutones A and B (1 and 2), two 1,3-diarylpropan-1-ols,
velutols C and D (3 and 4), a dihydroxychalcone,
velutone E (5), a chalcone, velutone F (6), a furanoflavanone, velutone G (7), and a furanoflavonol,
velutone H (8), and 14 known compounds were isolated
from Millettia velutina. Their structures
were determined by high-resolution electrospray ionisation mass spectrometry
(HR-ESIMS) and spectroscopic data analyses and time-dependent density
functional theory electronic circular dichroism (TD-DFT–ECD)
calculations. Among the isolated constituents, compound 6 exhibited the most potent inhibitory effect (IC50: 1.3
μM) against nigericin-induced IL-1β release in THP-1 cells.
The initial mechanism of action study revealed that compound 6 suppressed NLRP3 inflammasome activation via blocking ASC oligomerization without affecting the priming step,
which subsequently inhibited caspase-1 activation and IL-1β
secretion. Most importantly, compound 6 exerted potent
protective effects in the LPS-induced septic shock mice model by improving
the survival rate of mice and suppressing serum IL-1β release.
These results demonstrated that compound 6 had the potential
to be developed as a broad-spectrum NLRP3 inflammasome inhibitor for
the treatment of NLRP3-related disease.